Abstract is: Motion sickness occurs due to a difference between actual and expected motion. Symptoms commonly include nausea, vomiting, cold sweat, headache, dizziness, tiredness, loss of appetite, and increased salivation. Complications may rarely include dehydration, electrolyte problems, or a lower esophageal tear. The cause of motion sickness is either real or perceived motion. This may include from car travel, air travel, sea travel, space travel, or reality simulation. Risk factors include pregnancy, migraines, and Ménière's disease. The diagnosis is based on symptoms. Treatment may include behavioral measures or medications. Behavioral measures include keeping the head still and focusing on the horizon. Three types of medications are useful: antimuscarinics such as scopolamine, H1 antihistamines such as dimenhydrinate, and amphetamines such as dexamphetamine. Side effects, however, may limit the use of medications. A number of medications used for nausea such as ondansetron are not effective for motion sickness. Nearly all people are affected with sufficient motion and most people will experience motion sickness at least once in their lifetime. Susceptibility, however, is variable, with about one-third of the population being highly susceptible while most other people are affected under extreme conditions. Women are more easily affected than men. Motion sickness has been described since at least the time of Homer (c. eighth century BC).
head and neck disease | Q55789477 |
class of disease | Q112193867 |
disease | Q12136 |
genetic disease | Q200779 |
genetic otorhinolaryngologic disease | Q55788308 |
genetic nervous system disorder | Q55788492 |
inner ear disease | Q18555242 |
P8785 | AniDB tag ID | 2553 |
P2581 | BabelNet ID | 00049140n |
00049140n | ||
P1617 | BBC Things ID | 3b4365fa-7a7a-4e99-b66f-d3f7ba82e879 |
P268 | Bibliothèque nationale de France ID | 12154039n |
P508 | BNCF Thesaurus ID | 54242 |
P9272 | DeCS ID | 28181 |
P973 | described at URL | https://www.nationalgeographic.com/travel/article/motion-sickness-seasickness-prevention-wristbands-glasses?utm_source=pocket-newtab-global-en-GB |
P699 | Disease Ontology ID | DOID:2951 |
P557 | DiseasesDB | 11908 |
P10565 | Encyclopedia of China (Third Edition) ID | 457909 |
P1417 | Encyclopædia Britannica Online ID | science/motion-sickness |
P3219 | Encyclopædia Universalis ID | mal-des-transports |
P2888 | exact match | http://identifiers.org/doid/DOID:2951 |
http://purl.obolibrary.org/obo/DOID_2951 | ||
P11956 | Experimental Factor Ontology ID | 0006928 |
P646 | Freebase ID | /m/0gxcc |
P7464 | Genetics Home Reference Conditions ID | motion-sickness |
P12385 | Gran Enciclopèdia Catalana ID | cinetosi |
P1296 | Gran Enciclopèdia Catalana ID (former scheme) | 0090605 |
P11514 | Great Russian Encyclopedia portal ID | ukachivanie-d3fe17 |
P4229 | ICD-10-CM | T75.3 |
P7807 | ICD-11 ID (Foundation) | 1078108554 |
P7329 | ICD-11 ID (MMS) | NF08.3 |
P1692 | ICD-9-CM | 994.6 |
P3827 | JSTOR topic ID (archived) | motion-sickness |
P244 | Library of Congress authority ID | sh85087559 |
P486 | MeSH descriptor ID | D009041 |
P672 | MeSH tree code | C23.888.571 |
P6366 | Microsoft Academic ID | 2777740769 |
P5270 | Mondo ID | MONDO_0008015 |
P8189 | National Library of Israel J9U ID | 987007545930805171 |
P1368 | National Library of Latvia ID | 000331542 |
P1748 | NCI Thesaurus ID | C34824 |
P349 | NDL Authority ID | 00565129 |
P7995 | NHS Health A to Z ID | motion-sickness |
P1245 | OmegaWiki Defined Meaning | 1343872 |
P492 | OMIM ID | 158280 |
158280 | ||
P10283 | OpenAlex ID | C2779336972 |
P3417 | Quora topic ID | Motion-Sickness |
P5082 | Store medisinske leksikon ID | bevegelsessyke |
P10913 | UK Archival Thesaurus ID | f2/mt285/649/3032/8011/8060/8478/9353/8642 |
P2892 | UMLS CUI | C0026603 |
P12086 | WikiKids ID | Reisziekte |
P11143 | WikiProjectMed ID | Motion sickness |
P1343 | described by source | Brockhaus and Efron Encyclopedic Dictionary | Q602358 |
New Encyclopedic Dictionary | Q19190511 | ||
Meyers Konversations-Lexikon, 4th edition (1885–1890) | Q19219752 | ||
Great Soviet Encyclopedia (1926–1947) | Q20078554 | ||
The Domestic Encyclopædia; Or, A Dictionary Of Facts, And Useful Knowledge | Q56441911 | ||
Small Brockhaus and Efron Encyclopedic Dictionary | Q19180675 | ||
P2176 | drug or therapy used for treatment | L-scopolamine | Q337188 |
chlorcyclizine | Q2393323 | ||
(RS)-meclizine | Q386441 | ||
dimenhydrinate | Q420439 | ||
(±)-promethazine | Q422970 | ||
bromodiphenhydramine | Q4926102 | ||
P1995 | health specialty | neurology | Q83042 |
otolaryngology | Q189553 | ||
emergency medicine | Q2861470 | ||
P5008 | on focus list of Wikimedia project | WikiProject Medicine | Q4099686 |
P910 | topic's main category | Category:Motion sickness | Q18698915 |
FileName: Sea-sickness - published by G.S. Tregear, 96 Cheapside (cropped).jpg
Description: Print published by Gabriel Shear Tregear (1802 - February 21, 1841). This artwork is in the public domain because the artist died more than 100 years ago.
Artist: Daderot
License: Public domain
Q66399126 | A Comparative Bioavailability and Adhesion Performance Study, Comparing a New Scopolamine Transdermal Delivery System Formulation to the Currently Established Reference Transdermal Delivery System in Healthy Adult Participants. |
Q79111141 | Analysis of Vestibular Compensation Following Vestibular Neurectomy |
Q64173375 | Clinical Evaluation of the Use of Ginger Extract in the Management of Motion Sickness |
Q65358677 | Countermeasures to Reduce Sensorimotor Impairment and Space Motion Sickness Resulting From Altered Gravity Levels |
Q83794763 | DPI 386 Nasal Gel for the Prevention of Nausea Associated With Motion Sickness |
Q65474652 | Does a Migraine Medication Decrease Rotational Motion Sickness in People Suffering From Migraines? |
Q64610958 | Effect of Transcutaneous Vagal Nerve Stimulation on Reducing Visually Induced Motion Sickness in Healthy Volunteers |
Q61932555 | Effects of Transdermal Scopolamine on Occupational Performance |
Q66081186 | Evaluation and Characterization of Motion Sickness on Passengers Sailing on the Astrolabe |
Q64606890 | Levo Phencynonate Hydrochloride for the Prevention of Seasickness |
Q113889007 | Meclizine Plasma Levels in Responders and Non-responders |
Q64819493 | Motion Sickness Medications and Vestibular Time Constant |
Q62031182 | Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness |
Q89153332 | Motion Syros: A Randomized Study Investigating the Efficacy of Tradipitant in Treating Motion Sickness |
Q86254521 | Nasal Gel Under Military Operational Conditions for the Prevention of Nausea Associated With Motion Sickness |
Q79110008 | Nasal Gel for the Prevention and Treatment of Nausea Associated With Motion Sickness |
Q107501012 | Nasal Gel for the Prevention of Nausea and Vomiting Associated With Motion |
Q113910365 | Non-pharmaceutical Motion Sickness Mitigation |
Q65355714 | Pharmacokinetic and Efficacy Profile Intranasal Scopolamine Spray |
Q66064439 | Prevention and Treatment of Nausea Associated With Motion Sickness in Senior Subjects |
Q66076634 | Research on Quantification of VR(Virtual Reality) Related Stress and Relaxation |
Q89507658 | Sensory Training for Orientation and Balance |
Q97047536 | Sensory Training for Visual Motion Sickness |
Q64186075 | Study of the Safety and Efficacy of DPI-386 Nasal Gel on Ocean-Going Vessels |
Q66064637 | The Prevention and Treatment of Nausea Associated With Motion Sickness |
Q115207063 | MKL1888:Seekrankheit |
Q71719060 | "Torso rotation" experiments; 1: Adaptation to motion sickness does not correlate with changes in VOR gain |
Q71719063 | "Torso rotation" experiments; 2: Gaze stability during voluntary head movements improves with adaptation to motion sickness |
Q43047564 | (--)-Hyoscine and cyclizine as motion sickness remedies |
Q100739582 | A Deep Motion Sickness Predictor Induced by Visual Stimuli in Virtual Reality |
Q51618916 | A Wearable Device Providing a Visual Fixation Point for the Alleviation of Motion Sickness Symptoms. |
Q38581550 | A cholinomimetic model of motion sickness and space adaptation syndrome |
Q78584936 | A clinical view of motion sickness research |
Q79804353 | A comparison of motion sickness prevalence between seafarers and non-seafarers onboard naval platforms |
Q55034098 | A comparison of motion sickness remedies in severe sea conditions. |
Q68027933 | A double-blind placebo controlled evaluation of acupressure in the treatment of motion sickness |
Q81726736 | A drop-tower experiment to determine the threshold of gravity for inducing motion sickness in fish |
Q51854385 | A method for evaluating effects of visually-induced motion sickness using ICA for photoplethysmography. |
Q48562023 | A misconception of motion sickness leads to false therapeutic expectations |
Q73690650 | A motion sickness maximum around the 0.2 Hz frequency range of horizontal translational oscillation |
Q43773649 | A new goldfish model to evaluate pharmacokinetic and pharmacodynamic effects of drugs used for motion sickness in different gravity loads |
Q43955363 | A new method of evaluating the rheoencephalogram and its use in studying the state of motion sickness |
Q80286230 | A note on Wendt's views of the importance of psychological factors in motion sickness |
Q43349889 | A novel animal model for motion sickness and its first application in rodents |
Q99400201 | A novel method for reducing motion sickness susceptibility through training visuospatial ability - A two-part study |
Q37304446 | A pilot study of rizatriptan and visually-induced motion sickness in migraineurs |
Q71095810 | A primer of vestibular function, spatial disorientation, and motion sickness |
Q44357900 | A provocative test for grading susceptibility to motion sickness yielding a single numerical score |
Q44110409 | A randomised, placebo-controlled study comparing two formulations of dimenhydrinate with respect to efficacy in motion sickness and sedation |
Q36633265 | A statistical analysis of motion sickness incidence data. |
Q52725778 | A statistical examination of three approaches for predicting motion sickness incidence. |
Q93567937 | A stimulator for laboratory studies of motion sickness in cats |
Q80669757 | A subsequent report on dramamine: the prophylactic and therapeutic control of motion sickness |
Q71154007 | A sudden-stop vestibulovisual test for rapid assessment of motion sickness manifestations |
Q46646552 | A survey of recent motion sickness research |
Q38581221 | A survey of the occurrence of motion sickness amongst passengers at sea. |
Q71533409 | A theory of motion sickness based on pharmacological reactions |
Q69010527 | A two-factor model of rotation-induced motion sickness syndrome in squirrel monkeys |
Q76506845 | ADRENAL CORTICAL RESPONSE IN MOTION SICKNESS |
Q36366008 | AVP modulation of the vestibular nucleus via V1b receptors potentially contributes to the development of motion sickness in rat. |
Q46723713 | Active posture control during experimental motion sickness in guinea-pigs |
Q68785508 | Acupressure and motion sickness |
Q24187060 | Acupressure for motion sickness |
Q24198054 | Acupressure for motion sickness |
Q24243700 | Acupressure for motion sickness |
Q49176718 | Acupressure relieves the symptoms of motion sickness and reduces abnormal gastric activity. |
Q50048672 | Acupuncture relieves motion sickness via the IRβ-ERK1/2-dependent insulin receptor signalling pathway |
Q84928863 | Acute hyperglycemia is related to gastrointestinal symptoms in motion sickness: an experimental study |
Q70900037 | Adaptation of the Visual Vertical during Prolonged Body Tilt Varies with Susceptibility to Motion Sickness |
Q75392977 | Adaptation of the vestibulo-ocular reflex, subjective tilt, and motion sickness to head movements during short-radius centrifugation |
Q54572080 | Adaptation to experimental motion sickness in dogs. |
Q51740021 | Adaptation to motion sickness from torso rotation affects symptoms from supine head nodding. |
Q44450172 | Adaptation to optokinetic rotation-induced motion sickness without experiencing nausea |
Q69662609 | Adaptation to vection-induced symptoms of motion sickness |
Q69778941 | Aerobic fitness and susceptibility to motion sickness |
Q52296398 | Age-related differences for motion sickness in the rat. |
Q69909364 | Alleviation of motion sickness by nifedipine |
Q57207048 | Alterations in R–R variability associated with experimental motion sickness |
Q69575300 | Altered susceptibility to motion sickness as a function of subgravity level |
Q91539141 | Ameliorative Effect of Hesperidin Against Motion Sickness by Modulating Histamine and Histamine H1 Receptor Expression |
Q40950929 | Aminalon as an agent for the prevention of motion sickness |
Q91044910 | An Active Suspension System for Mitigating Motion Sickness and Enabling Reading in a Car |
Q83294580 | An HPLC-ESI-MS method for simultaneous determination of fourteen metabolites of promethazine and caffeine and its application to pharmacokinetic study of the combination therapy against motion sickness |
Q74474476 | An appraisal of the value of vitamin B12 in the prevention of motion sickness |
Q64120654 | An evaluation for VR glasses system user experience: The influence factors of interactive operation and motion sickness |
Q42033472 | An outline of current motion sickness research |
Q91158974 | Analysis on Mitigation of Visually Induced Motion Sickness by Applying Dynamical Blurring on a User's Retina |
Q43764765 | Animal model of motion sickness in rats |
Q46848428 | Animal models of motion sickness: are nonemetic species an appropriate choice? |
Q68051081 | Another approach to motion sickness |
Q74677400 | Antidiuresis as a measurement of laboratory induced motion sickness |
Q24193669 | Antihistamines for motion sickness |
Q24241865 | Antihistamines for motion sickness |
Q75488669 | Antihistaminics and motion sickness prophylaxis |
Q54134716 | Appropriateness of kaolin consumption as an index of motion sickness in the rat. |
Q44166012 | Are evolutionary hypotheses for motion sickness "just-so" stories? |
Q34589889 | Are there side effects to watching 3D movies? A prospective crossover observational study on visually induced motion sickness |
Q38567128 | Artificial horizon effects on motion sickness and performance |
Q71576462 | Asian hypersusceptibility to motion sickness |
Q88411024 | Assessment of Olfactory Perception in Individuals with Motion Sickness |
Q69198016 | Asymmetric otolith function and increased susceptibility to motion sickness during exposure to variations in gravitoinertial acceleration level |
Q73068959 | Autogenic-feedback training exercise is superior to promethazine for control of motion sickness symptoms |
Q79868341 | Autonomic responses during motion sickness induced by virtual reality |
Q45928548 | Axis rotation and visually induced motion sickness: the role of combined roll, pitch, and yaw motion. |
Q46418112 | Baclofen, motion sickness susceptibility and the neural basis for velocity storage |
Q30332648 | Behavioral methods of alleviating motion sickness: effectiveness of controlled breathing and a music audiotape. |
Q49090870 | Behavioural genetics of early childhood: fears, restlessness, motion sickness and enuresis. |
Q82806221 | Bitter taster status predicts susceptibility to vection-induced motion sickness and nausea |
Q86833577 | Body load and the postural precursors of motion sickness |
Q46664029 | Both migraine and motion sickness may be due to low brain levels of serotonin |
Q42176635 | Brain Activation by H1 Antihistamines Challenges Conventional View of Their Mechanism of Action in Motion Sickness: A Behavioral, c-Fos and Physiological Study in Suncus murinus (House Musk Shrew) |
Q26992868 | Brainstem processing of vestibular sensory exafference: implications for motion sickness etiology |
Q69439635 | Buspirone blocks motion sickness and xylazine-induced emesis in the cat |
Q50129420 | Cabin location and the likelihood of motion sickness in cruise ship passengers |
Q68858159 | Calcium antagonists in the prevention of motion sickness |
Q50060010 | Can passengers' active head tilt decrease the severity of carsickness? Effect of head tilt on severity of motion sickness in a lateral acceleration environment |
Q82097481 | Cardiovascular changes in motion sickness |
Q48702590 | Central Aspects of Drugs for Motion Sickness and Vertigo1 |
Q73687455 | Central nervous pathways of experimental motion sickness |
Q69066026 | Cerebrospinal fluid constituents of cat vary with susceptibility to motion sickness |
Q69127242 | Change in the external respiration function during motion sickness |
Q93004589 | Changes in skin blood flow, respiration and blood pressure in participants reporting motion sickness during sinusoidal galvanic vestibular stimulation |
Q71432901 | Changes in subjective estimates of well-being during the onset and remission of motion sickness symptomatology in the slow rotation room |
Q51583856 | Changes in the gastrointestinal electric pattern to motion sickness in susceptibles and insusceptibles during fasting. |
Q44738639 | Circulation and oxygen tension in the brain of the alert rabbit during motion sickness |
Q97884384 | Clinical Evaluation of the Use of Ginger Extract in the Preventive Management of Motion Sickness |
Q51335380 | Clinical aviation and aerospace medicine. Bethanechol chloride in the treatment of motion sickness: negative results |
Q43940600 | Clinical problems in aviation medicine. Relationship between past history of motion sickness and attrition from flight training |
Q52545887 | Cognitive and postural precursors of motion sickness in adolescent boxers. |
Q82047740 | Comment on Visual pattern repsonses in migraine with and without motion sickness |
Q71287761 | Committee to advise on tropical medicine and travel (CATMAT). Statement on motion sickness |
Q68832303 | Comparative assessment of vestibular, optokinetic, and optovestibular stimulation in the development of experimental motion sickness |
Q41012713 | Comparative evaluation of the effectiveness of seduxen and cyclodol and their combination with electropulse action for the purpose of increasing the resistance to experimental motion sickness |
Q31007604 | Comparison of evaluation methods on changes of facial microcirculation during induction of motion sickness |
Q32066296 | Comparison of granisetron, droperidol, and metoclopramide for prevention of postoperative vomiting in children with a history of motion sickness undergoing tonsillectomy |
Q67539562 | Comparison of susceptibility to motion sickness during rotation at 30 rpm in the earth-horizontal, 10 degrees head-up, and 10 degrees head-down positions |
Q42144684 | Comparison of the effects of a selective muscarinic receptor antagonist and hyoscine (scopolamine) on motion sickness, skin conductance and heart rate |
Q68707968 | Comparison of various motion stimuli on motion sickness and acquisition of adaptation in Suncus Murinus |
Q70596310 | Computerized task battery assessment of cognitive and performance effects of acute phenytoin motion sickness therapy |
Q49112456 | Conditioned taste aversion and motion sickness in cats and squirrel monkeys |
Q48720548 | Console video games, postural activity, and motion sickness during passive restraint |
Q41650161 | Contribution of intravestibular sensory conflict to motion sickness and dizziness in migraine disorders |
Q84173690 | Control of a virtual vehicle influences postural activity and motion sickness |
Q27333709 | Controlling motion sickness and spatial disorientation and enhancing vestibular rehabilitation with a user-worn see-through display |
Q66886334 | Coriolis acceleration. Vestibulo-vegetative stimulations with regard to the motion sickness of astronauts. Experimental researches |
Q33537639 | Coriolis effects and motion sickness modelling |
Q79738681 | Correlation of phasic and tonic skin-conductance responses with severity of motion sickness induced by viewing an optokinetic rotating drum |
Q38787195 | Correlations between individual susceptibility to visually induced motion sickness and decaying time constant of after-nystagmus. |
Q46023605 | Cortisol levels predict motion sickness tolerance in women but not in men. |
Q48216446 | Cross-coupling vestibular stimulation: motion sickness and the vestibulo-sympathetic reflex. |
Q43317804 | Decreased Fos protein expression in rat caudal vestibular nucleus is associated with motion sickness habituation |
Q70134534 | Decreased susceptibility to motion sickness during exposure to visual inversion in microgravity |
Q92841628 | Decreasing motion sickness by mixing different techniques |
Q83920706 | Delimitation of central nervous mechanisms involved in motion sickness |
Q95805210 | Demand characteristics in assessing motion sickness in a virtual environment: or does taking a motion sickness questionnaire make you sick? |
Q30435422 | Demonstrating the potential for dynamic auditory stimulation to contribute to motion sickness |
Q50124140 | Dependence of motion sickness in automobiles on the direction of linear acceleration |
Q33680792 | Determinants of Motion Sickness in Tilting Trains: Coriolis/Cross-Coupling Stimuli and Tilt Delay |
Q41989463 | Development of a melting tablet containing promethazine HCl against motion sickness |
Q87255282 | Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system |
Q72042522 | Diagnostic criteria for grading the severity of acute motion sickness |
Q41024220 | Differences in otolith and abdominal viscera graviceptor dynamics: implications for motion sickness and perceived body position. |
Q27309183 | Differential Gene Expression Profile in the Rat Caudal Vestibular Nucleus is Associated with Individual Differences in Motion Sickness Susceptibility |
Q50490116 | Display color affects motion sickness symptoms in an optokinetic drum. |
Q33909485 | Dizziness in discus throwers is related to motion sickness generated while spinning |
Q123955660 | Domestic Encyclopædia (1802)/Sea-sickness |
Q80949899 | Dramamine and Motion Sickness |
Q77694697 | Drinking milk or water has no effect on the severity of optokinetic rotation-induced symptoms of motion sickness |
Q33170741 | Drug effectiveness on experimental optokinetic and vestibular motion sickness |
Q41575805 | Drug treatment of motion sickness: scopolamine alone and combined with ephedrine in real and simulated situations. |
Q70769433 | Drugs for motion sickness |
Q73564423 | Drugs preventing motion sickness at sea |
Q33825572 | Dynamic Cardiovagal Response to Motion Sickness: A Point-Process Heart Rate Variability Study. |
Q51633483 | Dynamic characteristics between the subjective score of motion sickness discomfort and video global motion |
Q70625514 | Dynamics of subjective discomfort in motion sickness as measured with a magnitude estimation method |
Q40436908 | EEG based time and frequency dynamics analysis of visually induced motion sickness (VIMS). |
Q50864169 | EEG effects of motion sickness induced in a dynamic virtual reality environment. |
Q47771872 | EEG-based learning system for online motion sickness level estimation in a dynamic vehicle environment |
Q73905231 | EVALUATION of drugs for protection against motion sickness aboard transport ships; report of study by Army, Navy, Air Force motion sickness team |
Q51673844 | Effect of Breathing Supplemental Oxygen on Motion Sickness in Healthy Adults |
Q45960845 | Effect of Prophylactic Medication on Associated Dizziness and Motion Sickness in Migraine. |
Q44390648 | Effect of antiemetic drugs on decrease in gastric emptying in experimental model of motion sickness in rats. |
Q80304645 | Effect of body position on incidence of motion sickness |
Q38558372 | Effect of direction of head movement on motion sickness caused by Coriolis stimulation |
Q72284045 | Effect of drugs in altering susceptibility to motion sickness in aerobatics and the slow rotation room |
Q78663903 | Effect of drugs on motion sickness produced by short exposures to artificial waves |
Q70496204 | Effect of environmental temperature on sweat onset during motion sickness |
Q52311156 | Effect of frequency of horizontal linear oscillation on motion sickness and somatogravic illusion. |
Q74473340 | Effect of hypoxia on motion sickness induced by optokinetic stimulation |
Q71146482 | Effect of motion sickness on stomach potential in dogs before and after labyrinthectomy |
Q41695367 | Effect of motion sickness on the absorption of B group vitamins and ascorbic acid in the small intestine of dogs |
Q66884512 | Effect of motion sickness on the activity of certain blood serum enzymes and the functional state of the sympathoadrenal system |
Q50922290 | Effect of passengers' active head tilt and opening/closure of eyes on motion sickness in lateral acceleration environment of cars. |
Q73251616 | Effect of roll oscillation frequency on motion sickness |
Q46664049 | Effect of tryptophan depletion on symptoms of motion sickness in migraineurs |
Q80317959 | Effect on marksmanship of some motion sickness preparations containing barbiturates and hyoscine |
Q58272582 | Effects and Side-Effects of Motion Sickness Preparations |
Q92386717 | Effects of Immersive Virtual Reality Headset Viewing on Young Children: Visuomotor Function, Postural Stability, and Motion Sickness |
Q48272675 | Effects of N-methyl-D-aspartate antagonists on different measures of motion sickness in cats |
Q50026853 | Effects of Physical Driving Experience on Body Movement and Motion Sickness During Virtual Driving |
Q58299918 | Effects of Vestibular Cerebellum Lesion on Motion Sickness in Rats |
Q92298575 | Effects of Visually Induced Motion Sickness on Emergency Braking Reaction Times in a Driving Simulator |
Q49127780 | Effects of amygdala or hippocampus lesion on hypergravity-induced motion sickness in rats |
Q51777925 | Effects of anti-motion sickness drugs on motion sickness in rats. |
Q45398020 | Effects of decades of physical driving on body movement and motion sickness during virtual driving. |
Q70970282 | Effects of dimenhydrinate on gastric tachyarrhythmia and symptoms of vection-induced motion sickness |
Q68218154 | Effects of eating on vection-induced motion sickness, cardiac vagal tone, and gastric myoelectric activity |
Q44204795 | Effects of ethnicity and gender on motion sickness susceptibility. |
Q73078659 | Effects of gender of subjects and experimenter on susceptibility to motion sickness |
Q78952546 | Effects of ginger on motion sickness and gastric slow-wave dysrhythmias induced by circular vection |
Q70216539 | Effects of ginger on motion sickness susceptibility and gastric function |
Q72181922 | Effects of motion sickness and antimotion sickness drugs on gastric function |
Q71156701 | Effects of motion sickness on the dynamic characteristics of responses to Coriolis stimulation. SAM-TR-65-67 |
Q84890548 | Effects of motion sickness on thermoregulatory responses in a thermoneutral air environment |
Q43152866 | Effects of motion sickness severity on the vestibular-evoked myogenic potentials |
Q38951297 | Effects of naloxone on motion sickness in cats alone and with broad spectrum antiemetics |
Q77693940 | Effects of navigation speed on motion sickness caused by an immersive virtual environment |
Q51595115 | Effects of phenytoin on vection-induced motion sickness and gastric myoelectric activity. |
Q68201333 | Effects of pre-exposures to a rotating optokinetic drum on adaptation to motion sickness |
Q39536221 | Effects of proposed preflight adaptation training on eye movements, self-motion perception, and motion sickness: a progress report |
Q52315247 | Effects of repeated administration of the psychophysiological test for motion sickness susceptibility. |
Q70540058 | Effects of scopolamine on autonomic profiles underlying motion sickness susceptibility |
Q68441271 | Effects of serotonin antagonists on motion sickness and its suppression by 8-OH-DPAT in cats |
Q50803919 | Effects of some motion sickness suppressants on static and dynamic tracking performance. |
Q73209379 | Effects of spatial frequency of a vertically striped rotating drum on vection-induced motion sickness |
Q94599504 | Effects of synchronised engine sound and vibration presentation on visually induced motion sickness |
Q46536123 | Effects of transcutaneous electrical nerve stimulation on motion sickness induced by rotary chair: a crossover study |
Q88682492 | Effects of unexpected visual motion on postural sway and motion sickness |
Q71000939 | Effects of vection-induced motion sickness on gastric myoelectric activity and oral-cecal transit time |
Q46484633 | Effects of vestibular training on motion sickness, nystagmus, and subjective vertical. |
Q79707901 | Effects of virtual body motion on visually-induced motion sickness |
Q36996965 | Effects of visceral inputs on the processing of labyrinthine signals by the inferior and caudal medial vestibular nuclei: ramifications for the production of motion sickness |
Q38572037 | Efficacy and safety of maropitant, a selective neurokinin 1 receptor antagonist, in two randomized clinical trials for prevention of vomiting due to motion sickness in dogs |
Q38573169 | Efficacy of maropitant for preventing vomiting associated with motion sickness in dogs |
Q70083303 | Efficacy of phosphatidylcholine in the modulation of motion sickness susceptibility |
Q47163798 | Electroacupuncture Could Reduce Motion Sickness Susceptibility in Healthy Male Adults: A Double-Blinded Study. |
Q69051113 | Electrodermal activity as an index of motion sickness |
Q70959063 | Electroencephalographic studies on a dimenhydrinate in a chewing-gum for motion sickness |
Q51621961 | Electrogastrograms during motion sickness in fasted and fed subjects. |
Q70580681 | Elicitation of motion sickness by head movements in the microgravity phase of parabolic flight maneuvers |
Q70121372 | Endocrine correlates of susceptibility to motion sickness |
Q37779187 | Eradication of Helicobacter pylori infection aids with the outcome of motion sickness adaptation |
Q41030171 | Estimated body rotation as a predictor of motion sickness susceptibility |
Q50863403 | Estimation of effects of visually-induced motion sickness using independent component analysis. |
Q72181932 | Etiologic significance of arginine vasopressin in motion sickness |
Q40230275 | Etiology and treatment of motion sickness: a review. |
Q67502695 | Etiopathogenesis of motion sickness |
Q28075565 | Evaluation of Motion Sickness Induced by 3D Video Clips |
Q36102507 | Evaluation of adaptation to visually induced motion sickness based on the maximum cross-correlation between pulse transmission time and heart rate |
Q50865922 | Evaluation of adaptation to visually induced motion sickness by using physiological index associated with baroreflex function. |
Q43639581 | Evaluation of motion sickness by some hemodynamic indices |
Q40833272 | Evaluation of motion sickness susceptibility by motion sickness susceptibility questionnaire in adolescents with idiopathic scoliosis: a case-control study. |
Q75503261 | Evaluation of some drugs in motion sickness |
Q71154086 | Evaluation of the relationship between motion sickness symptomatology and blood pressure, heart rate, and body temperature |
Q41535209 | Evidence for a motion sickness agent in cerebrospinal fluid |
Q98212550 | Examining potential effects of arousal, valence, and likability of music on visually induced motion sickness |
Q90627097 | Expanded table: some drugs for altitude illness, jet lag, and motion sickness |
Q74631401 | Experimental motion sickness in dogs: role of abdominal visceral afferents |
Q73554148 | Experimental motion sickness in dogs; functional importance of chemoceptive emetic trigger zone |
Q51331340 | Experimental motion sickness in dogs; importance of labyrinth and vestibular cerebellum. |
Q52270040 | Experimental motion sickness induced in squirrel monkeys by continuous off-axis horizontal rotation. |
Q70863867 | Experimental motion sickness: efficacy of transdermal scopolamine plus ephedrine |
Q40674205 | Experimental study of some aspects of the etiopathogenesis of motion sickness |
Q73504929 | Experimentally induced motion sickness in fish: possible role of the otolith organs |
Q104070612 | Exploring the utility of EDA and skin temperature as individual physiological correlates of motion sickness |
Q50764665 | Eye movement, vection, and motion sickness with foveal and peripheral vision. |
Q74112209 | Eye movements to yaw, pitch, and roll about vertical and horizontal axes: adaptation and motion sickness |
Q75354244 | Facial pain increases nausea and headache during motion sickness in migraine sufferers |
Q80955150 | Factors influencing the susceptibility of anurans to motion sickness |
Q82136479 | Fatal poisoning from motion sickness preventive |
Q57114140 | Feeling queasy. EMS providers should be aware that many patients can experience motion sickness while riding in the ambulance |
Q87049081 | Frequency characteristics of visually induced motion sickness |
Q52266480 | Frequency effect of 0.35-1.0 Hz horizontal translational oscillation on motion sickness and the somatogravic illusion. |
Q30499003 | Function of the special senses in flight. II: motion sickness and noise and communication |
Q75951035 | Further experiments on the prevention of motion sickness |
Q38466081 | Gastric arrhythmia and nausea of motion sickness induced in healthy Japanese subjects viewing an optokinetic rotating drum |
Q73297027 | Gender differences in motion sickness history and susceptibility to optokinetic rotation-induced motion sickness |
Q69735335 | General autonomic components of motion sickness |
Q93144395 | Genetic Analysis of a Large Family with Migraine, Vertigo, and Motion Sickness |
Q51777783 | Genetic influences on motion sickness susceptibility in adult women: a classical twin study. |
Q30635212 | Genetic variants associated with motion sickness point to roles for inner ear development, neurological processes and glucose homeostasis |
Q52333994 | Genetical and Developmental Aspects of Susceptibility to Motion Sickness and Frost-bite |
Q48102327 | Gravitation biology using fish as model systems for understanding motion sickness susceptibility. |
Q52237597 | Habituation of motion sickness in the cat. |
Q51951342 | Hand preference, susceptibility to motion sickness, and differential vulnerability to psychiatric admission. |
Q73687451 | Head movements and motion sickness |
Q38592858 | Head movements in low and high gravitoinertial force environments elicit motion sickness: implications for space motion sickness |
Q38592586 | Head movements in non-terrestrial force environments elicit motion sickness: implications for the etiology of space motion sickness |
Q82863098 | Heart rate variability and motion sickness during forklift simulator driving |
Q78079974 | Heinrich Heines Gedichte – ein Mittel gegen die Seekrankheit |
Q28239527 | High dose ondansetron for reducing motion sickness in highly susceptible subjects |
Q68180706 | Histaminergic response to Coriolis stimulation: implication for transdermal scopolamine therapy of motion sickness |
Q49494856 | History of High Motion Sickness Susceptibility Predicts Vestibular Dysfunction Following Sport/Recreation-Related Concussion |
Q77394365 | History of motion sickness is predictive of childhood migraine |
Q68605205 | Hormonal changes after parabolic flight: implications on the development of motion sickness |
Q70198310 | Hormone hypothesis joins factors under study in motion sickness |
Q35415438 | How to study placebo responses in motion sickness with a rotation chair paradigm in healthy participants |
Q73993368 | Human heart rate variability relation is unchanged during motion sickness |
Q77815534 | Human otolith-ocular reflexes during off-vertical axis rotation: effect of frequency on tilt-translation ambiguity and motion sickness |
Q40917118 | Human susceptibility to motion sickness |
Q70225319 | Human susceptibility to motion sickness in combined vestibular and optokinetic stimulation with a reduced field of vision |
Q71853856 | Hypertension and motion sickness |
Q80408841 | Hyperventilation in a motion sickness desensitization program |
Q74358547 | I heard that the adhesive patch you can wear to prevent motion sickness is available again. Why was it taken off the market? |
Q78340316 | INDUCTION OF RESISTANCE TO MOTION SICKNESS THROUGH REPEATED EXPOSURE TO CORIOLIS STIMULATION. SAM-TR-64-87 |
Q78431239 | INFLUENCE OF INTEROCEPTIVE AFFERENTATION ON THE EXCITABILITY OF VOMITING CENTER IN MOTION SICKNESS |
Q43599994 | Idaverine, an M2- vs. M3-selective muscarinic antagonist, does not prevent motion sickness in cats |
Q27329682 | Identification of neural networks that contribute to motion sickness through principal components analysis of fos labeling induced by galvanic vestibular stimulation |
Q48297401 | Ig Nobel awards celebrate studies of motion sickness, bladder control, and a mayor with an armoured tank |
Q33734242 | Illusory self-motion and motion sickness: a model for brain-gut interactions and nausea. |
Q38552477 | Immersed false vertical room. A new motion sickness model |
Q84544421 | Impact of alignment to gravito-inertial force on motion sickness and cardiopulmonary variables |
Q96135470 | Incidence and severity of Visually Induced motion Sickness during 3D laparoscopy In Operators who had No experience with it (VISION) |
Q67261841 | Increased secretion of growth hormone, prolactin, antidiuretic hormone, and cortisol induced by the stress of motion sickness |
Q41525171 | Individual differences in motion sickness susceptibility: a further test of the "receptivity" hypothesis |
Q39589941 | Individual differences in susceptibility to motion sickness among six Skylab astronauts |
Q70446146 | Influence of a visual display and frequency of whole-body angular oscillation on incidence of motion sickness |
Q40822699 | Influence of different conditions for tilt compensation on symptoms of motion sickness in tilting trains |
Q74470753 | Influence of endurance exercise performance on hemodynamic and hormonal responses to lower body negative pressure (LBNP) and +Gz tolerance in the aspect of individual sensitivity to motion sickness |
Q42228803 | Influence of transdermal scopolamine on motion sickness during 7 days' exposure to heavy seas |
Q69099388 | Influence of vision on susceptibility to acute motion sickness studied under quantifiable stimulus-response conditions |
Q90280457 | Inner ear AVP-V2R-AQP2 signaling pathway is involved in the induction of motion sickness |
Q39286139 | Instability of the perceived world while watching 3D stereoscopic imagery: A likely source of motion sickness symptoms |
Q83225655 | Integrated evaluation of visually induced motion sickness in terms of autonomic nervous regulation |
Q26823866 | Integration of vestibular and emetic gastrointestinal signals that produce nausea and vomiting: potential contributions to motion sickness |
Q52261433 | Intensification and habituation of experimental motion sickness in squirrel monkeys by repeated horizontal rotation. |
Q51280827 | Intensity of motion sickness symptoms as a function of apparent autonomic balance. |
Q51854383 | Interpolation of the subjective score of visually-induced motion sickness by using physiological parameters. |
Q70138191 | Intramuscular hyoscine in control of motion sickness |
Q91010018 | Intranasal Scopolamine for Motion Sickness |
Q51779681 | Investigation of motion sickness and inertial stability on a moving couch for intra-fraction motion compensation. |
Q41605697 | Investigation of visually induced motion sickness in dynamic 3D contents based on subjective judgment, heart rate variability, and depth gaze behavior |
Q48145535 | Is the noradrenergic neuron system in the brain stem related to motion sickness in rats? |
Q77105809 | Keeping motion sickness at bay |
Q90569291 | Knowing What's Coming: Unpredictable Motion Causes More Motion Sickness |
Q90342324 | Knowing what's coming: Anticipatory audio cues can mitigate motion sickness |
Q75205305 | Korean hand acupressure for motion sickness in prehospital trauma care: a prospective, randomized, double-blinded trial in a geriatric population |
Q41485762 | Labyrinthine and extralabyrinthine mechanisms of the development of motion sickness in weightlessness |
Q73687444 | Labyrinthine factors in motion sickness |
Q30474040 | Labyrinthine lesions and motion sickness susceptibility |
Q70372690 | Lack of effects of astemizole on vestibular ocular reflex, motion sickness, and cognitive performance in man |
Q46305494 | Lack of gender difference in motion sickness induced by vestibular Coriolis cross-coupling. |
Q70113016 | Locomotion and motion sickness during horizontally and vertically reversed vision |
Q45002265 | Locomotion and motion sickness under horizontal and vertical reversal of vision |
Q37609289 | Low level of swiprosin-1/EFhd2 in vestibular nuclei of spontaneously hypersensitive motion sickness mice. |
Q82110164 | MANAGEMENT of motion sickness |
Q76628878 | MECHANISM OF MOTION SICKNESS IN THE CAT |
Q53040662 | MOTION SICKNESS ON RAILROADS |
Q78345573 | MOTION SICKNESS SYMPTOMATOLOGY OF LABYRINTHINE DEFECTIVE AND NORMAL SUBJECTS DURING ZERO GRAVITY MANEUVERS |
Q78295574 | MOTION SICKNESS SYMPTOMATOLOGY OF LABYRINTHINE DEFECTIVE AND NORMAL SUBJECTS DURING ZERO GRAVITY MANEUVERS. TECHN DOCUM REP NO. AMRL-TDR-64-47 |
Q82176149 | MOTION sickness remedies |
Q82142230 | MOTION sickness; hyoscine best preventive of travel ills now known but its effectiveness is limited |
Q38564044 | Mal de debarquement, motion sickness and the effect of an artificial horizon |
Q50940857 | Male/female differences in drug-induced emesis and motion sickness in Suncus murinus. |
Q60341507 | Measuring visually induced motion sickness using wearable devices |
Q83321242 | Mechanism of motion sickness |
Q58299016 | Mechanisms of Motion Sickness as Reflected in the Vertigo and Nystagmus Responses to Repeated Caloric Stimuli |
Q70759623 | Medications for Vertigo and Motion Sickness |
Q33167975 | Meniere's, migraine, and motion sickness |
Q34089509 | Mental rotation: a key to mitigation of motion sickness in the virtual environment? |
Q82130567 | Methods of assaying motion sickness preventives on dogs |
Q70610568 | Michigan's space shuttle pilot suffered motion sickness |
Q40141948 | Microcapsule-gel formulation of promethazine HCl for controlled nasal delivery: a motion sickness medication |
Q58867807 | Migraine and motion sickness independently contribute to visual discomfort |
Q51823959 | Migraine and motion sickness independently contribute to visual discomfort. |
Q37736664 | Migraine and motion sickness: what is the link? |
Q34995539 | Modafinil as a potential motion sickness countermeasure |
Q39176543 | Model of motion sickness in dogs for assessing the effectiveness of pharmacological substances |
Q33537637 | Modelling motion sickness and subjective vertical mismatch detailed for vertical motions. |
Q71130314 | More on motion sickness |
Q93862071 | More on motion sickness |
Q58271689 | Motion Sickness Induced by Sinusoidal Linear Acceleration in Rats |
Q40124140 | Motion Sickness Prediction in Aeromedical Evacuation of Patients with Ebola. |
Q91828437 | Motion Sickness Prediction in Stereoscopic Videos using 3D Convolutional Neural Networks |
Q92928428 | Motion Sickness Predictors in College Students and Their First Experience Sailing at Sea |
Q92900086 | Motion Sickness Susceptibility and Baseline Vestibular and Ocular-Motor Performance in Adolescent Athletes |
Q41515769 | Motion Sickness Susceptibility and Solution Choice in a Pragmatic Paradox |
Q52100629 | Motion Sickness Susceptibility: Population Profiles in a General Psychiatric Population and in Heroin Addicts and Alcoholics |
Q38560294 | Motion Sickness and Resting Energy Expenditure in Chinese Male Adults |
Q70484118 | Motion Sickness and Travellers Diarrhoea |
Q61311243 | Motion Sickness, Console Video Games, and Head-Mounted Displays |
Q52321514 | Motion Sickness, Field Dependence, and Levels of Development |
Q40650528 | Motion Sickness: An Evolutionary Hypothesis |
Q38603260 | Motion Sickness: Current Knowledge and Recent Advance |
Q41515763 | Motion Sickness: an Index of Sensory Conflict Relating to Behavior |
Q87247463 | Motion control, motion sickness, and the postural dynamics of mobile devices |
Q61606551 | Motion in images is essential to cause motion sickness symptoms, but not to increase postural sway |
Q41179171 | Motion sickness (author's transl) |
Q51359505 | Motion sickness aboard jet aircraft; preliminary report. |
Q86217211 | Motion sickness adaptation to Coriolis-inducing head movements in a sustained G flight simulator |
Q55502496 | Motion sickness adaptation: a neural mismatch model |
Q48272578 | Motion sickness amelioration induced by prism spectacles |
Q39615811 | Motion sickness and anxiety |
Q33537632 | Motion sickness and development of synergy within the spatial orientation system. A hypothetical unifying concept |
Q68038470 | Motion sickness and equilibrium ataxia |
Q69625783 | Motion sickness and gastric myoelectric activity as a function of speed of rotation of a circular vection drum |
Q52756035 | Motion sickness and its prevention by drugs. |
Q79527608 | Motion sickness and its relief |
Q83274841 | Motion sickness and its relief |
Q80184076 | Motion sickness and migraine |
Q77999849 | Motion sickness and migraine: optokinetic stimulation increases scalp tenderness, pain sensitivity in the fingers and photophobia |
Q67999949 | Motion sickness and motion characteristics of vessels at sea |
Q66916007 | Motion sickness and occipital spiking in the electroencephalogram |
Q74420869 | Motion sickness and otolith asymmetry |
Q41057141 | Motion sickness and otolith sensitivity: a pilot study of habituation to linear acceleration |
Q35660079 | Motion sickness and perception: a reappraisal of the sensory conflict approach |
Q43889770 | Motion sickness and postoperative vomiting in children |
Q45079281 | Motion sickness and postural sway in console video games |
Q42595945 | Motion sickness and proprioceptive aftereffects following virtual environment exposure |
Q52768840 | Motion sickness and space sickness: clinical and experimental findings. |
Q95555604 | Motion sickness and spatial perception. A theoretical study |
Q51207465 | Motion sickness and the reticular formation. |
Q50102898 | Motion sickness and tilts of the inertial force environment: active suspension systems vs. active passengers. |
Q45041721 | Motion sickness and travellers' diarrhoea |
Q73018717 | Motion sickness and vestibular hypersensitivity |
Q48634439 | Motion sickness as a predictor of postoperative vomiting in children aged 1-16 years |
Q42737244 | Motion sickness as a problem in the Armed Forces |
Q90424320 | Motion sickness as metaphor: engaging with diversity in STEM |
Q70578722 | Motion sickness at sea |
Q45288844 | Motion sickness caused by by 'rollercoaster flight' |
Q70829224 | Motion sickness caused by rotations about Earth-horizontal and Earth-vertical axes |
Q53855150 | Motion sickness decreases arterial pressure and therefore acceleration tolerance. |
Q72036659 | Motion sickness due to vision reversal: its absence in stroboscopic light |
Q50089871 | Motion sickness during fore-and-aft oscillation: effect of the visual scene. |
Q52312540 | Motion sickness during off-vertical axis rotation: prediction by a model of sensory interactions and correlation with other forms of motion sickness. |
Q81486345 | Motion sickness from combined lateral and roll oscillation: effect of varying phase relationships |
Q48434662 | Motion sickness history, food neophobia, and sensation seeking. |
Q44024733 | Motion sickness in USAF flying personnel. |
Q78837879 | Motion sickness in a helicopter simulator |
Q72546850 | Motion sickness in amphibians |
Q91700523 | Motion sickness in automated vehicles with forward and rearward facing seating orientations |
Q66920691 | Motion sickness in cats: a symptom rating scale used in laboratory and flight tests |
Q80366691 | Motion sickness in children |
Q70939360 | Motion sickness in children with tourette's syndrome |
Q72834944 | Motion sickness in children: ochopathy-naupathy |
Q67381622 | Motion sickness in dogs and cats |
Q50140063 | Motion sickness in guinea pigs (Cavia porcellus) indexed by body rotation-induced conditioned taste aversions |
Q52214922 | Motion sickness in mice and conditioned taste aversion. |
Q42582798 | Motion sickness in migraine and vestibular disorders |
Q36326249 | Motion sickness in migraine sufferers |
Q48649748 | Motion sickness in operational bomber crews. |
Q91700293 | Motion sickness in passenger vehicles during test track operations |
Q39940181 | Motion sickness in pilot trainees: management to keep them flying |
Q38578451 | Motion sickness in public road transport: passenger behavior and susceptibility. |
Q38578177 | Motion sickness in public road transport: the effect of driver, route and vehicle. |
Q73342508 | Motion sickness in public road transport: the relative importance of motion, vision and individual differences |
Q50166900 | Motion sickness in quail: body-rotation-induced conditioned fluid aversions in C. coturnix japonica |
Q43787527 | Motion sickness in rally car co-drivers |
Q41431194 | Motion sickness in the aerospace environment |
Q75610924 | Motion sickness in the military service |
Q71496552 | Motion sickness in the squirrel monkey |
Q69750574 | Motion sickness incidence as a function of the frequency and acceleration of vertical sinusoidal motion |
Q71560194 | Motion sickness incidence during a round-the-world yacht race |
Q52719863 | Motion sickness incidence induced by complex periodic waveforms. |
Q52693322 | Motion sickness incidence: distribution of time to first emesis and comparison of some complex motion conditions. |
Q47145540 | Motion sickness increases functional connectivity between visual motion and nausea-associated brain regions. |
Q79924024 | Motion sickness increases the risk of accidental hypothermia |
Q35235066 | Motion sickness induced by off-vertical axis rotation (OVAR). |
Q76308490 | Motion sickness induced by optokinetic drums |
Q51873181 | Motion sickness induced by otolith stimulation is correlated with otolith-induced eye movements. |
Q85597191 | Motion sickness induces intestinal transit increase in mice |
Q48153793 | Motion sickness is associated with an increase in vestibular modulation of skin but not muscle sympathetic nerve activity |
Q46432554 | Motion sickness is linked to nystagmus-related trigeminal brain stem input: a new hypothesis |
Q70760405 | Motion sickness is often caused by anxiety over the trip |
Q45982202 | Motion sickness may be caused by a neurohumoral action of acetylcholine. |
Q73862892 | Motion sickness occurrence does not correlate with nystagmus characteristics |
Q35497039 | Motion sickness on tilting trains |
Q74454032 | Motion sickness potentiates core cooling during immersion in humans |
Q83364096 | Motion sickness preceded by unstable displacements of the center of pressure |
Q43779078 | Motion sickness precipitated in the weightless phase of parabolic flight by Coliolis accelerations. NAMI-1061 |
Q72437529 | Motion sickness precipitated in the weightless phase of parabolic flight by coriolis accelerations |
Q48074192 | Motion sickness prevalence in school children |
Q86435359 | Motion sickness prevention by an 8-Hz stroboscopic environment during air transport |
Q71539852 | Motion sickness produced by head movement as a function of rotational velocity |
Q80277056 | Motion sickness provoked by torso rotation |
Q80239359 | Motion sickness provoked by torso rotation predicts that caused by head nodding |
Q67364791 | Motion sickness questionnaire and field independence scores as predictors of success in naval aviation training |
Q48337470 | Motion sickness reflex arc bypasses the area postrema in cats |
Q70153145 | Motion sickness severity and physiological correlates during repeated exposures to a rotating optokinetic drum |
Q45342776 | Motion sickness severity under interaction of vection and head movements |
Q36576342 | Motion sickness susceptibility |
Q44253370 | Motion sickness susceptibility and aerobic fitness: a longitudinal study |
Q51022183 | Motion sickness susceptibility and related behavioral characteristics in men and women. |
Q43598117 | Motion sickness susceptibility and the utilisation of visual and otolithic information for orientation |
Q47777433 | Motion sickness susceptibility associated with visually induced postural instability and cardiac autonomic responses in healthy subjects |
Q77050908 | Motion sickness susceptibility correlates with otolith- and canal-ocular reflexes |
Q49089666 | Motion sickness susceptibility due to a small hematoma in the right supramarginal gyrus |
Q77604314 | Motion sickness susceptibility during rotation at 30 rpm in free-fall parabolic flight |
Q51836072 | Motion sickness susceptibility fluctuates through the menstrual cycle. |
Q44608381 | Motion sickness susceptibility in healthy subjects and vestibular patients: effects of gender, age and trait-anxiety. |
Q70153140 | Motion sickness susceptibility in parabolic flight and velocity storage activity |
Q71384239 | Motion sickness susceptibility in student navigators |
Q71131452 | Motion sickness susceptibility patterns of psychotic illness |
Q48272569 | Motion sickness susceptibility questionnaire revised and its relationship to other forms of sickness |
Q40943382 | Motion sickness susceptibility to optokinetic rotation correlates to past history of motion sickness |
Q72437557 | Motion sickness susceptibility under weightless and hypergravity conditions generated by parabolic flight |
Q71118060 | Motion sickness susceptibility under weightless and hypergravity conditions generated by parabolic flight. NAMI-1057 |
Q67414804 | Motion sickness susceptibility: a retrospective comparison of laboratory tests |
Q39106725 | Motion sickness symptomatology and performance decrements occasioned by hurricane penetrations in C-121, C-130 and P-3 navy aircraft |
Q96292064 | Motion sickness symptoms during jumping exercise on a short-arm centrifuge |
Q51923046 | Motion sickness symptoms in a ship motion simulator: effects of inside, outside, and no view. |
Q50074073 | Motion sickness with combined fore-aft and pitch oscillation: effect of phase and the visual scene |
Q64964877 | Motion sickness with combined lateral and roll oscillation: effect of percentage compensation. |
Q83306921 | Motion sickness with fully roll-compensated lateral oscillation: effect of oscillation frequency |
Q82324890 | Motion sickness with special reference to air sickness |
Q48404028 | Motion sickness, body movement, and claustrophobia during passive restraint |
Q72524094 | Motion sickness, ginger, and psychophysics |
Q93910375 | Motion sickness, migraine, and menstruation in mariners |
Q37226585 | Motion sickness, nausea and thermoregulation: The "toxic" hypothesis |
Q33588600 | Motion sickness, stress and the endocannabinoid system |
Q70741935 | Motion sickness, vascular changes accompanying pseudo-coriolis-induced nausea |
Q40134047 | Motion sickness: A modulatory role for the central cholinergic nervous system |
Q81333134 | Motion sickness: Some theoretical and practical considerations |
Q84776659 | Motion sickness: a cholinomimetic agent hypothesis |
Q39202756 | Motion sickness: a disease caused by transportation |
Q37609626 | Motion sickness: a negative reinforcement model |
Q78881688 | Motion sickness: a psychophysiologic gastrointestinal reaction? |
Q71140307 | Motion sickness: a special case of sensory rearrangement |
Q37905203 | Motion sickness: a synthesis and evaluation of the sensory conflict theory |
Q71725598 | Motion sickness: acquisition and retention of adaptation effects compared in three motion environments |
Q36690027 | Motion sickness: advances in pathogenesis, prediction, prevention, and treatment. |
Q38183416 | Motion sickness: an evolutionary and genetic basis for the negative reinforcement model |
Q90219055 | Motion sickness: an overview |
Q41979532 | Motion sickness: comparison of metoclopramide and diphenhydramine to placebo |
Q38572047 | Motion sickness: effect of changes in magnitude of combined lateral and roll oscillation |
Q80491015 | Motion sickness: effect of the frequency of lateral oscillation |
Q44528171 | Motion sickness: effect of the magnitude of roll and pitch oscillation |
Q49017750 | Motion sickness: its pathophysiology and treatment. |
Q38222913 | Motion sickness: more than nausea and vomiting |
Q33537634 | Motion sickness: only one provocative conflict? |
Q71154037 | Motion sickness: part I--a theory |
Q47961400 | Motion sickness: part II--a clinical study based on surgery of cerebral hemisphere lesions. |
Q71154041 | Motion sickness: part III--a clinical study based on surgery of posterior fossa tumors |
Q35214600 | Motion sickness: review of causes and preventive strategies. |
Q41210067 | Motion sickness: the resonance hypothesis |
Q26766497 | Moving in a Moving World: A Review on Vestibular Motion Sickness |
Q37460036 | Musk shrews selectively bred for motion sickness display increased anesthesia-induced vomiting |
Q80379267 | NEW drug in motion sickness |
Q69585735 | Naloxone enhances motion sickness: endorphins implicated |
Q68275262 | Neurologic aspects of motion sickness |
Q40883120 | Neuropharmacology of motion sickness and emesis. A review |
Q67988204 | Neuropsychiatric observations of proprioceptive sensitivity in motion sickness susceptibility |
Q80296013 | New drug effective in motion sickness |
Q71506886 | New factors in migraine, motion sickness and equilibrium. A cybernetic study of equilibrium |
Q78827769 | New medication for treatment of motion sickness |
Q66905544 | New thoughts on motion sickness |
Q59329428 | No Gain No Pain: Relations Between Vestibulo-Ocular Reflexes and Motion Sickness in Mice |
Q34174029 | Nuclear medicine evaluation of motion sickness and medications on gastric emptying time |
Q44423036 | Nystagmus, turning sensations, and illusory movement in motion sickness susceptibility |
Q103046582 | Objective and subjective responses to motion sickness: the group and the individual |
Q73938525 | Objective and subjective time courses of recovery from motion sickness assessed by repeated motion challenges |
Q98628636 | Ocular counter-rolling in scuba divers with motion sickness |
Q83313943 | Ocular vestibular evoked myogenic potentials and motion sickness susceptibility |
Q53089487 | Off vertical axis rotation motion sickness and field dependence. |
Q73469603 | On a common dynamic factor in motion sickness |
Q43722665 | Opioid receptor involvement in the adaptation to motion sickness in Suncus murinus |
Q58309319 | Optokinetic Motion Sickness And Pseudo-Coriolis Effects Induced By Moving Visual Stimuli |
Q73251607 | Optokinetic drum tilt hastens the onset of vection-induced motion sickness |
Q41667593 | Optokinetic motion sickness: attenuation of visually-induced apparent self-rotation by passive head movements |
Q46142314 | Optokinetic motion sickness: continuous head movements attenuate the visual induction of apparent self-rotation and symptoms of motion sickness |
Q77694702 | Optokinetic nystagmus correlates with severity of vection-induced motion sickness and gastric tachyarrhythmia |
Q78518261 | Optokinetic nystagmus, vection, and motion sickness |
Q52201286 | Optokinetic rotation-induced taste aversions correlate with over-all symptoms of motion sickness in humans. |
Q77935469 | Optokinetic stimuli: motion sickness, visual acuity, and eye movements |
Q50041394 | Orientation Preferences and Motion Sickness Induced in a Virtual Reality Environment |
Q36923250 | Orientation perception, motion sickness and vertigo: Beyond the sensory conflict approach |
Q54025197 | Orthostatic intolerance and motion sickness after parabolic flight. |
Q77891768 | Otolith signal processing and motion sickness |
Q46971181 | Oxidative stress is not involved in motion sickness in mice. |
Q71780336 | P6 acupressure reduces symptoms of vection-induced motion sickness |
Q73687459 | Passenger comfort in commercial air travel with reference to motion sickness |
Q53666304 | Passive restraint reduces visually induced motion sickness in older adults. |
Q30877935 | Pathophysiology and treatment of motion sickness |
Q52164736 | Pavlovian conditioning of taste aversion using a motion sickness paradigm. |
Q98224574 | Perceptual Validation of Nonlinear Postural Predictors of Visually Induced Motion Sickness |
Q72464008 | Pharmacologic agents for preventing and treating motion sickness |
Q68832315 | Pharmacological interventions for motion sickness: cardiovascular effects |
Q68099161 | Phasic skin conductance activity and motion sickness |
Q46770558 | Phenylthiocarbamide taste perception and susceptibility to motion sickness: linking higher susceptibility with higher phenylthiocarbamide taste acuity |
Q70741933 | Phenytoin as a countermeasure for motion sickness in NASA maritime operations |
Q72110457 | Phenytoin for motion sickness: clinical evaluation |
Q73687442 | Philosophical perspectives of motion sickness |
Q28138034 | Physiological basis and pharmacology of motion sickness: an update |
Q68096575 | Pica as an index of motion sickness in rats |
Q52307904 | Pica: A species relevant behavioral assay of motion sickness in the rat |
Q46757860 | Plasma vasopressin, an etiologic factor of motion sickness in rat and human? |
Q48735423 | Postural activity and motion sickness during video game play in children and adults |
Q33145995 | Postural instability and motion sickness in a fixed-based flight simulator |
Q33647750 | Postural instability and motion sickness in a virtual moving room |
Q98383882 | Postural precursors of motion sickness in head-mounted displays: Drivers and passengers, women and men |
Q77486415 | Posture, locomotion, spatial orientation, and motion sickness as a function of space flight |
Q51151044 | Precursors of post-bout motion sickness in adolescent female boxers. |
Q74496565 | Predicting motion sickness during parabolic flight |
Q47947154 | Predicting vection and visually induced motion sickness based on spontaneous postural activity. |
Q69400943 | Prediction of the incidence of motion sickness from the magnitude, frequency, and duration of vertical oscillation |
Q89459069 | Prevalence of motion sickness in various vestibular disorders: a study on 749 patients |
Q40391896 | Prevalence, Predictors, and Prevention of Motion Sickness in Zero-G Parabolic Flights. |
Q79252423 | Prevention and treatment of motion sickness |
Q95463570 | Prevention and treatment of motion sickness |
Q73916601 | Prevention and treatment of motion sickness by intranasal medication |
Q67496196 | Prevention of experimental motion sickness by scopolamine absorbed through the skin |
Q80623143 | Prevention of motion sickness by intravenous injection of sodium bicarbonate |
Q46982793 | Prevention of motion sickness by means of intravenous injection of sodium bicarbonate |
Q67350376 | Prevention of motion sickness in flight maneuvers, aided by transfer of adaptation effects acquired in the laboratory: ten consecutive referrals |
Q46862272 | Prevention of motion sickness with rizatriptan: a double-blind, placebo-controlled pilot study. |
Q38239321 | Prevention of motion sickness with selegilinum hydrochloricum |
Q71109758 | Prevention of overt motion sickness by incremental exposure to otherwise highly stressful Coriolis accelerations. NAMI-1044 |
Q52337122 | Prevention of overt motion sickness by incremental exposure to otherwise highly stressful coriolis accelerations |
Q73969664 | Prevention of postoperative vomiting with granisetron in paediatric patients with and without a history of motion sickness |
Q72347032 | Primary Osteoarthritis, Migraine Headaches, and Motion Sickness |
Q69789622 | Proceedings: An evaluation of cupulometry as a predictor of susceptibility to motion sickness |
Q36674698 | Processing of vestibular inputs by the medullary lateral tegmental field of conscious cats: implications for generation of motion sickness |
Q71076515 | Progress in the therapy of motion sickness: the dimenhydrinate-containing chewing gum dragee |
Q35239256 | Prolonged reduction of motion sickness sensitivity by visual-vestibular interaction |
Q48710991 | Promethazine as a motion sickness treatment: impact on human performance and mood states. |
Q71670077 | Prophylactic effect of serotonin uptake inhibitors against motion sickness in Suncus murinus |
Q41839811 | Proposed mechanisms and treatment strategies for motion sickness disorder: a case series |
Q43831782 | Protective action of peptides against motion sickness in animals |
Q83355783 | Psychological factors in susceptibility to motion sickness |
Q38805941 | Psychometric Properties of the Greek Version of the Gianaros Motion Sickness Assessment Questionnaire |
Q41693889 | Psychophysiological aspects of motion sickness |
Q60341522 | Quantifying Visually Induced Motion Sickness (VIMS) During Stereoscopic 3D Viewing Using Temporal VIMS Rating |
Q70950656 | Quantitative evaluation of the clinical manifestations of motion sickness |
Q79707905 | Quantitative evaluation of the effect of visually-induced motion sickness using causal coherence function between blood pressure and heart rate |
Q75930294 | RECENT studies on the treatment of motion sickness |
Q90593164 | Real-time visual feedback about postural activity increases postural instability and visually induced motion sickness |
Q76166063 | Recent studies on the treatment of motion sickness |
Q70392957 | Reducing motion sickness: a comparison of autogenic-feedback training and an alternative cognitive task |
Q51300616 | Reduction of motion sickness in prehospital trauma care. |
Q47884590 | Reduction of motion sickness through targeting histamine N-methyltransferase in the dorsal vagal complex of the brain |
Q44212301 | Reduction of motion sickness with an enhanced placebo instruction: an experimental study with healthy participants |
Q69717268 | Reduction of visually-induced motion sickness elicited by changes in illumination wavelength |
Q33153430 | Relation between motion sickness susceptibility and vasovagal syncope susceptibility |
Q72214955 | Relations between motion sickness susceptibility, the spiral after-effect and loudness estimation |
Q42775536 | Relationship among sexual differences of susceptibility to motion sickness, AVP levels of plasma and pituitary and V1b receptor expression of pituitary in rats |
Q35866378 | Relationship between Spectral Characteristics of Spontaneous Postural Sway and Motion Sickness Susceptibility |
Q69498228 | Relationship between motion sickness experience and tests of the perception of rotation in pilots and nonpilots |
Q88457941 | Relationship between motion sickness susceptibility and vestibulo-ocular reflex gain and phase |
Q48272649 | Relationship between motion sickness, migraine and menstruation in crew members of a "round the world" yacht race |
Q48272620 | Relationship between postural control and motion sickness in healthy subjects |
Q33982612 | Relationship between temporal changes in cardiac parasympathetic activity and motion sickness severity. |
Q66875257 | Relationships of fatigue and motion sickness to vestibulo-ocular responses to coriolis stimulation |
Q41313861 | Reliability of provocative tests of motion sickness susceptibility |
Q46472225 | Reliability of psychophysiological responses across multiple motion sickness stimulation tests |
Q90717633 | Reliability of the Thai Version of the Motion Sickness Susceptibility Questionnaire Short-Form |
Q70542379 | Relief of vection-induced motion sickness |
Q56935227 | Research in visually induced motion sickness |
Q84328267 | Respiratory impact on motion sickness induced by linear motion |
Q57817642 | Responding to Other People's Posture: Visually Induced Motion Sickness From Naturally Generated Optic Flow |
Q69091442 | Response from arousal and thermal sweat areas during motion sickness |
Q61767416 | Retraction Note to: Prevention of PONV with granisetron, droperidol and metoclopramide in female patients with history of motion sickness |
Q34771010 | Rizatriptan reduces vestibular-induced motion sickness in migraineurs |
Q84758689 | Role of AQP1 in inner ear in motion sickness |
Q55980469 | Role of Histamine H1 Receptors in Vestibular Nucleus in Motion Sickness |
Q43844836 | Role of autonomic nervous system for development and suppression of motion sickness in Suncus murinus |
Q69591394 | Role of changes in hormonal status in the development of motion sickness in man |
Q48634034 | Role of histamine in motion sickness in Suncus murinus |
Q73322783 | Role of plasma vasopressin as a mediator of nausea and gastric slow wave dysrhythmias in motion sickness |
Q43314676 | Role of the area postrema in three putative measures of motion sickness in the rat. |
Q81239041 | Rotation direction change hastens motion sickness onset in an optokinetic drum |
Q83291464 | Rotation direction change hastens motion sickness onset in an optokinetic drum |
Q73275587 | Rotation of subjective vertical is an important factor of visually-induced motion sickness |
Q80114660 | Rotation velocity change and motion sickness in an optokinetic drum |
Q78436529 | SOME ISSUES IN THE DEVELOPMENT OF A MOTION SICKNESS QUESTIONNAIRE FOR FLIGHT STUDENTS. RES REP. NSAM-916 |
Q76669625 | STUDIES OF MOTION SICKNESS: XIX. THE EFFICIENCY OF LABORATORY TESTS OF THE PREVENTIVE ACTION OF DRUGS |
Q28279681 | Safety, pharmacokinetics and use of the novel NK-1 receptor antagonist maropitant (Cerenia) for the prevention of emesis and motion sickness in cats |
Q62937258 | Salivary changes associated with experimental motion sickness condition in man |
Q69287266 | Scopoderm: transdermal hyoscine for motion sickness |
Q24236610 | Scopolamine (hyoscine) for preventing and treating motion sickness |
Q24244421 | Scopolamine (hyoscine) for preventing and treating motion sickness |
Q24246624 | Scopolamine for preventing and treating motion sickness |
Q43571925 | Scopolamine nasal spray in motion sickness: a randomised, controlled, and crossover study for the comparison of two scopolamine nasal sprays with oral dimenhydrinate and placebo |
Q42280874 | Scopolamine plaster caused hallucination. Toxic psychosis in a 10-year-old boy caused by an agent against motion sickness |
Q94529260 | Scopolamine sublingual spray: an alternative route of delivery for the treatment of motion sickness |
Q82088214 | Selection of men for aeronautical training based on susceptibility to motion sickness |
Q48272269 | Self-induced motion sickness in unperturbed stance |
Q70490354 | Semicircular canals as a primary etiological factor in motion sickness |
Q42764329 | Sensation of presence and cybersickness in applications of virtual reality for advanced rehabilitation |
Q36889988 | Sensory conflict compared in microgravity, artificial gravity, motion sickness, and vestibular disorders |
Q72919762 | Separation of affective disorder into seasonal and nonseasonal types using motion sickness susceptibility as a marker |
Q93643950 | Serum levels of eleven steroid hormones following motion sickness |
Q97589544 | Severe motion sickness in infants and children |
Q86198915 | Sex Differences in the Incidence of Motion Sickness Induced by Linear Visual Oscillation |
Q37642037 | Sex and Age Differences in Motion Sickness in Rats: The Correlation with Blood Hormone Responses and Neuronal Activation in the Vestibular and Autonomic Nuclei |
Q73721228 | Side effects of remedies for motion sickness |
Q73269721 | Slow deep breathing prevents the development of tachygastria and symptoms of motion sickness |
Q58307948 | Some Animal Experiments on Motion Sickness |
Q73721234 | Some effects of motion sickness remedies upon psychologic performance |
Q79124832 | Some experiments on the relative effectiveness of various types of accelerations on motion sickness |
Q79514657 | Some issues in the development of a motion sickness questionnaire for flight students |
Q71088535 | Some issues in the development of a motion sickness questionnaire for flight students. Res Rep NSAM-916 |
Q79372084 | Some new neurophysiological studies on motion sickness and its therapy |
Q41924183 | Some observations concerning the mode of action of the antihistaminic drug "lergigan" (N(alpha-methyl-beta-dimethyl aminoethyl)phenothiazine hydrochloride) in motion sickness |
Q41814915 | Some psychological correlates of motion sickness susceptibility |
Q93651855 | Space flight: IV. Variables of motion sickness |
Q68527812 | Space motion sickness |
Q72217807 | Space motion sickness |
Q79190633 | Space motion sickness |
Q51952213 | Spatial task performance, sex differences, and motion sickness susceptibility. |
Q70540068 | Spectral analysis of the electroencephalographic response to motion sickness |
Q71092933 | Speed of recovery from Coriolis stimulation in motion sickness in relation to pilots and nonpilots. SAM-TR-66-63 |
Q36455158 | Statistical analysis of censored motion sickness latency data using the two-parameter Weibull distribution |
Q37661303 | Storage of passive motion pattern in hippocampal CA1 region depends on CaMKII/CREB signaling pathway in a motion sickness rodent model |
Q46900844 | Stroboscopic vision as a treatment for motion sickness: strobe lighting vs. shutter glasses |
Q71113089 | Structural elements in the concept of motion sickness |
Q83276072 | Studies of motion sickness; the effects upon sickness rates of waves of various frequencies but identical acceleration |
Q82146377 | Studies on experimental motion sickness |
Q49009852 | Studies on motion sickness caused by high curve speed railway vehicles. Evaluation of the swing and its effects on passengers and conductors. |
Q67773255 | Study of the flight work capacity of pilots during simulated motion sickness |
Q72157914 | Study on experimental motion sickness in children |
Q42049078 | Subjective concomitants of motion sickness: quantifying rotation-induced illness in squirrel monkeys |
Q69921744 | Suncus murinus as a new experimental model for motion sickness |
Q69983516 | Suppression of motion sickness by thiethylperazine (Torecan) |
Q92006344 | Survey of motion sickness susceptibility in children and adolescents aged 3 months to 18 years |
Q40665046 | Susceptibility to Motion Sickness and Ego Closeness, Ego Distance as Measured by the Autokinetic Response Tendency |
Q52119355 | Susceptibility to Reflex Vestibular Disturbances and Motion Sickness as a Function of Mental States of Alertness and Sleep1 |
Q71511645 | Susceptibility to acute motion sickness in blind persons |
Q70665530 | Susceptibility to motion sickness |
Q72571861 | Susceptibility to motion sickness and chemotherapy-induced side-effects |
Q52112900 | Susceptibility to motion sickness and field dependence-independence as measured with the rod and frame test |
Q48629928 | Susceptibility to motion sickness and the development of anticipatory nausea and vomiting in cancer patients undergoing chemotherapy |
Q75219204 | Susceptibility to motion sickness in fish: a parabolic aircraft flight study |
Q77120168 | Susceptibility to motion sickness induced by optokinetic rotation and self-rotation by walking around a vertical pole |
Q87130824 | Susceptibility to motion sickness is not increased following spinal cord injury |
Q36851655 | Susceptibility to nausea and motion sickness as a function of the menstrual cycle |
Q73721216 | Symposium on motion sickness. II. Medication for motion sickness prior to and during World War II |
Q78125187 | Systematic investigation of physiological correlates of motion sickness induced by viewing an optokinetic rotating drum |
Q71115228 | Systemic naloxone increases the incidence of motion sickness in the cat |
Q76712118 | THE PENSACOLA SLOW ROTATION ROOM WITH SPECIAL REFERENCE TO DISORIENTATION AND MOTION SICKNESS IN SPACE FLIGHT |
Q78477884 | THE ROLE OF THE SEMICIRCULAR CANALS IN CAUSATION OF MOTION SICKNESS AND NYSTAGMUS IN THE DOG |
Q37717370 | TREATMENT OF MOTION SICKNESS: (A Review of Therapeutic Studies Sponsored by the National Research Council of Canada). |
Q55692966 | Targeting TRPV1 to relieve motion sickness symptoms in mice by electroacupuncture and gene deletion. |
Q58256788 | Teleology of Motion Sickness |
Q34274906 | Temporal change in NMDA receptor signaling and GABAA receptor expression in rat caudal vestibular nucleus during motion sickness habituation |
Q54881967 | The Effects of Optokinetic Nystagmus on Visually Induced Motion Sickness after the Confounding Effects of Retinal Slip is Controlled. |
Q53962240 | The Identification of Cases of Chronic Motion Sickness during Military Screening Examinations |
Q58569626 | The Neurophysiology and Treatment of Motion Sickness |
Q96164457 | The Relationship Between Vestibular Migraine and Motion Sickness Susceptibility |
Q47122730 | The Relationship between Spatial Velocity, Vection, and Visually Induced Motion Sickness: An Experimental Study |
Q90924539 | The Shepard-Risset Glissando: Identifying the Origins of Metaphorical Auditory Vection and Motion Sickness |
Q72643435 | The cerebellum as a predictor of neural messages--II. Role in motor control and motion sickness |
Q38418419 | The comparison of sensitivity of motion sickness between retinal degeneration fast mice and normal mice |
Q53638807 | The contribution of expectations to motion sickness symptoms and gastric activity. |
Q77806162 | The correlation between aerobic fitness and motion sickness susceptibility |
Q73334694 | The differential effect of a rotary visual field on susceptibles and nonsusceptibles to motion sickness |
Q70105967 | The effect of a susceptibility to motion sickness on the side effects of cancer chemotherapy |
Q52199486 | The effect of autogenic training and biofeedback on motion sickness tolerance. |
Q79512620 | The effect of barbiturates and other substances on motion sickness in dogs |
Q56935230 | The effect of internal and external fields of view on visually induced motion sickness |
Q46332858 | The effect of motion sickness on the diurnal rhythm of the sinus node of the heart conduction system |
Q48748398 | The effect of past experience on motion sickness produced by visual stimuli |
Q44126721 | The effect of serotonin and serotonin receptor antagonists on motion sickness in Suncus murinus |
Q82237952 | The effect of smoking nicotine tobacco versus smoking deprivation on motion sickness |
Q71801349 | The effect of tilted stripes in an optokinetic drum on gastric myoelectric activity and subjective reports of motion sickness |
Q69738456 | The effect of vestibuloprotectors on the cyclic nucleotide system in experimental motion sickness |
Q24540442 | The effect on motion sickness and oculomotor function of GR 38032F, a 5-HT3-receptor antagonist with anti-emetic properties |
Q52870587 | The effectiveness of a motion sickness counselling programme |
Q82186385 | The effectiveness of some motion sickness remedies in preventing air sickness in Air Force Navigation students |
Q48465809 | The effects of TTS-scopolamine, dimenhydrinate, lidocaine, and tocainide on motion sickness, vertigo, and nystagmus |
Q73479974 | The effects of age and sex on susceptibility to motion sickness |
Q68919735 | The effects of fixation and restricted visual field on vection-induced motion sickness |
Q89796187 | The effects of meclizine on motion sickness revisited |
Q70970286 | The effects of motion direction, body axis, and posture on motion sickness induced by low frequency linear oscillation |
Q28138240 | The effects of serotonin (5-HT3) receptor antagonists on gastric tachyarrhythmia and the symptoms of motion sickness |
Q88011605 | The effects of the selective muscarinic M3 receptor antagonist darifenacin, and of hyoscine (scopolamine), on motion sickness, skin conductance & cognitive function |
Q95554502 | The efficacy of trilafon in potentiating bonamine motion sickness prophylaxis in dogs |
Q43513302 | The incidence and effects of motion sickness among medical attendants during transport |
Q82132878 | The influence of a placebo, body position and medication on motion sickness |
Q52234596 | The influence of age on susceptibility to motion sickness in monkeys |
Q38958143 | The influence of sleep deprivation and oscillating motion on sleepiness, motion sickness, and cognitive and motor performance |
Q69512217 | The motion of a ship at sea and the consequent motion sickness amongst passengers |
Q91278396 | The neural basis of motion sickness |
Q73721221 | The newer therapy of motion sickness |
Q73687447 | The nonlabyrinthine causes of motion sickness |
Q68725518 | The pharmacologic absis for the control of motion sickness by drugs |
Q51621482 | The possible role of nystagmus in motion sickness: a hypothesis. |
Q47627447 | The prevention of motion sickness in orbital flight. |
Q75707592 | The prophylactic and therapeutic control of motion sickness and vestibular disturbances |
Q44463318 | The relation of motion sickness to the spatial-temporal properties of velocity storage |
Q71088542 | The relationship between past history of motion sickness and attrition from flight training. Res Rep NSAM-932 |
Q82144681 | The relationship of air sickness to other types of motion sickness |
Q70446148 | The relationship of motion sickness susceptibility to learned autonomic control for symptom suppression |
Q41172677 | The resonance hypothesis of motion sickness on earth |
Q52032581 | The retention of adaptation to motion sickness eliciting stimulation. |
Q41874782 | The role of cholinergic mechanisms in altering the functional activity of the rabbit brain during motion sickness |
Q51189360 | The role of motion sickness in predicting anticipatory nausea. |
Q67829758 | The role of resonance phenomena in motion sickness |
Q38209000 | The role of the parasympathetic nervous system in visually induced motion sickness: systematic review and meta-analysis |
Q48771395 | The significance of motion sickness in the vestibular system. |
Q69624805 | The spiral after effect (SAE) as a measure of motion sickness susceptibility and the effect on the SAE of an antimotion sickness drug and a central nervous system depressant |
Q43762076 | The stability of individual patterns of autonomic responses to motion sickness stimulation |
Q70770601 | The studies on motion sickness |
Q74013562 | The treatment of motion sickness |
Q52768740 | The use of alpha-ethyl-alpha-phenyl-glutarimide (Doriden) as a motion sickness preventive. |
Q81451613 | The use of motion sickness bands to control nausea and vomiting in a group of hospice patients |
Q48407221 | The virtual reality head-mounted display Oculus Rift induces motion sickness and is sexist in its effects |
Q84951164 | Today's Drugs: Prevention of Motion Sickness |
Q101053242 | Tradipitant in the Treatment of Motion Sickness: A Randomized, Double-Blind, Placebo-Controlled Study |
Q71438028 | Transderm Scop for prevention of motion sickness |
Q70183806 | Transdermal scopolamine for motion sickness |
Q34529525 | Transdermal scopolamine for prevention of motion sickness : clinical pharmacokinetics and therapeutic applications |
Q71972460 | Transdermal scopolamine in motion sickness |
Q67275284 | Transdermal scopolamine in the prevention of motion sickness at sea |
Q71137680 | Transdermal scopolamine in the prevention of motion sickness: evaluation of the time course of efficacy |
Q38608066 | Transdermal scopolamine: a review of its effects upon motion sickness, psychological performance, and physiological functioning |
Q72094452 | Transfer of habituation of motion sickness on change in body position between vertical and horizontal in a rotating environment |
Q73794285 | Travel and motion sickness |
Q82146490 | Treatment of experimental motion sickness in humans |
Q83274577 | Treatment of motion sickness |
Q44906048 | Treatment of motion sickness in parabolic flight with buccal scopolamine |
Q34186243 | Treatment of severe motion sickness with antimotion sickness drug injections |
Q50097195 | Triggers of motion sickness in migraine sufferers |
Q19231653 | Ueberfahrt nach England ohne Seekrankheit |
Q92399683 | Unstable coupling of body sway with imposed motion precedes visually induced motion sickness |
Q73493923 | Unusual vestibular and visual input in human dynamic balance as a motion sickness susceptibility test |
Q70950667 | Use of No-Shpa in combination with vitamins in motion sickness |
Q43636155 | Use of a motion sickness history questionnaire for prediction of simulator sickness. |
Q51693359 | Use of controlled diaphragmatic breathing for the management of motion sickness in a virtual reality environment. |
Q69122629 | Use of sodium bicarbonate as a means of treating and preventing motion sickness |
Q87026487 | Using bio-signals to evaluate multi discomfort in image viewing - balancing visually induced motion sickness and field of view |
Q51270217 | VESTIBULAR MECHANISM, MOTION SICKNESS, AND DRUG THERAPY. EXPERIMENTAL AND CLINICAL EVALUATIONS. |
Q92177065 | VR motion sickness recognition by using EEG rhythm energy ratio based on wavelet packet transform |
Q73014078 | Variables of movement amplitude and frequency in the development of motion sickness in Suncus murinus |
Q54400539 | Vasopressin and motion sickness in cats. |
Q35486655 | Vection and visually induced motion sickness: how are they related? |
Q36336219 | Vection is the main contributor to motion sickness induced by visual yaw rotation: Implications for conflict and eye movement theories. |
Q73415589 | Vector analysis of electrogastrography during motion sickness |
Q78539374 | Vegetative reactions in caloric and rotatory tests; a clinical study with special reference to motion sickness |
Q51841405 | Verification of motion sickness index in mice. |
Q36764631 | Vertical heterophoria and susceptibility to visually induced motion sickness |
Q38140778 | Vertigo and dizziness from environmental motion: visual vertigo, motion sickness, and drivers' disorientation |
Q70944767 | Vertigo, motion sickness and migraine |
Q93152759 | Vestibular Function and Motion Sickness Susceptibility: Videonystagmographic Evidence From Oculomotor and Caloric Tests |
Q67984700 | Vestibular and postural findings in the motion sickness syndrome |
Q33546350 | Vestibular autonomic regulation (including motion sickness and the mechanism of vomiting). |
Q82364243 | Vestibular dysfunction in migraine: effects of associated vertigo and motion sickness |
Q53099627 | Vestibular evoked myogenic potentials and motion sickness medications. |
Q83395314 | Vestibular functions in motion sickness susceptible individuals |
Q50433333 | Vestibular sensitivity in vestibular migraine: VEMPs and motion sickness susceptibility |
Q73637135 | Vestibular testing abnormalities in individuals with motion sickness |
Q96129390 | Vestibulo-Ocular Responses, Visual Field Dependence, and Motion Sickness in Aerobatic Pilots |
Q51685972 | Vestibulo-ocular reflex and motion sickness in figure skaters. |
Q84097153 | Vibrotactile stimulators and virtual 3-D audio countermeasures, training and motion sickness symptoms with a simulated graveyard spin illusion |
Q72104071 | Vision and motion sickness |
Q69550079 | Vision therapy as a treatment for motion sickness |
Q52681059 | Visual Occlusion Decreases Motion Sickness in a Flight Simulator. |
Q89657537 | Visual Vertigo, Motion Sickness, and Disorientation in Vehicles |
Q73050983 | Visual and vestibular components of motion sickness |
Q40971277 | Visual blur and motion sickness in an optokinetic drum |
Q38575572 | Visual field effects on motion sickness in cars. |
Q72074573 | Visual suppression of motion sickness |
Q68024225 | Visual suppression test using post-rotatory nystagmus. Clinical course in patients with motion sickness |
Q47753024 | Visually induced motion sickness can be alleviated by pleasant odors |
Q49009597 | Visually induced motion sickness predicted by postural instability |
Q51806371 | Visually induced motion sickness when viewing visual oscillations of different frequencies along the fore-and-aft axis: keeping velocity versus amplitude constant. |
Q80749757 | Visually induced motion sickness with radial displays: effects of gaze angle and fixation |
Q82771035 | Visually induced motion sickness, visual stress and photosensitive epileptic seizures: what do they have in common? - preface to the special issue |
Q52276053 | What you thought you knew about motion sickness isn't necessarily so. |
Q81885354 | Women suffer more motion sickness |
Q48350873 | Xylazine emesis, yohimbine and motion sickness susceptibility in the cat. |
Q46115953 | Yawning as a behavioral marker of mild motion sickness and sopite syndrome |
Q85356058 | [A randomized controlled trial: acclimatization training on the prevention of motion sickness in hot-humid environment] |
Q74469596 | [A study on central and peripheral nerve transmitter mechanism of motion sickness] |
Q73159144 | [Action of some drugs used in the prevention of motion sickness on the cholinesterase activity of the blood in man and in animals in vivo and in vitro] |
Q73391593 | [An experimental validation of pharmacological agents to arrest the vestibulo-autonomic syndrome (motion sickness)] |
Q70180504 | [Antiepileptic drugs in the combined medicinal prevention of motion sickness] |
Q73074757 | [Antihistamine therapy of motion sickness] |
Q73674168 | [Antihistamine-amphetamine therapy of motion sickness] |
Q73386288 | [Antihistaminics and motion sickness] |
Q71881989 | [Changes in pain sensitivity and neuronal activity of the sensorimotor cortex in experimental motion sickness in animals] |
Q67963281 | [Changes in the cerebral hemodynamics under the influence of piracetam and fenibut during motion sickness] |
Q69617704 | [Changes in the functional activity of cortical brain structures and their blood supply during motion sickness in the alert rabbit] |
Q68734028 | [Characteristics of motion sickness during prolonged otolith stimulation in anti-orthostatic position] |
Q70732011 | [Clinical and experimental studies on royal made ping an dan in preventing motion sickness] |
Q68794673 | [Comparative evaluation of the effectiveness of vestibular, optokinetic and optovestibular stimulation in the experimental model of motion sickness] |
Q77418129 | [Comparison between motion sickness induced by reversed vision and that by parallel swing] |
Q68624280 | [Condition of cell membranes in simulated motion sickness and use of alpha-tocopherol] |
Q71745293 | [Content of biogenic amines and their precursors in human blood during head-down tilt and in taking pharmacological agents to prevent the motion sickness syndrome] |
Q95479415 | [Controlled observation of the efficacy on motion sickness in the prevention and treatment with jianpixingnao needling therapy] |
Q68762035 | [Correlation of vertical optokinetic nystagmus and susceptibility to motion sickness in man] |
Q75609142 | [Does a prophylaxis exist for sea sickness and motion sickness in general?] |
Q70072383 | [Dynamics of the changes in the statistical indices of the cardiac rhythm of persons with various degrees of susceptibility to motion sickness] |
Q52012707 | [Effect of Gastrodia on rotation induced motion sickness in mice] |
Q54380555 | [Effect of adaptive biofeedback on the severity of vestibulo-autonomic symptoms of experimental motion sickness] |
Q68000196 | [Effect of dimephosphon on the blood circulation and oxygen tension in the brain of normal waking rabbits and in motion sickness] |
Q69021989 | [Effect of ephedrine on the blood supply and oxygen regimen of the brain during motion sickness] |
Q70092770 | [Effect of experimental motion sickness on postrotatory nystagmus and the illusion of counterrotation] |
Q69545944 | [Effect of pharmacological agents to prevent the motion sickness syndrome on the cardiovascular system in simulating the early period of adaptation to weightlessness] |
Q68097560 | [Effect of sound on various vestibulo-autonomic reactions in motion sickness] |
Q69221330 | [Effect of the drug Humex on the development of experimental motion sickness] |
Q70408529 | [Effectiveness of the preparation Gavinton in preventing motion sickness] |
Q78511395 | [Effects of motion sickness evoked by parallel swing stimulation on posture equilibrium] |
Q73277863 | [Effects of pikamilon on the brain water-electrolyte balance and in models of responses to the noise and vibration exposure, and their combination with motion sickness] |
Q70247830 | [Evaluation of the effectiveness of drugs for prevention of motion sickness] |
Q73798291 | [Experience with benadon in motion sickness] |
Q72037019 | [Experimental studies of motion sickness on board of a research ship] |
Q78842733 | [Image and quantity analysis of prostaglandin in rats' blood plasma and Na(+)-K(+)-ATPase in their cerebellum during the prevention of motion sickness by cinnarizine] |
Q68833003 | [Importance of phase asynchrony of sensory signals in the mechanisms of development of motion sickness] |
Q73506414 | [Individual differences in susceptibility to motion sickness] |
Q84941928 | [Interocular asymmetry of nystagmus and motion sickness] |
Q71881688 | [Intersensory interactions as the basis of methods in enhancing resistance to motion sickness] |
Q72081012 | [Mechanism of the change in glucose absorption in the intestines of dogs with motion sickness] |
Q73797836 | [Methods of testing susceptibility to motion sickness] |
Q74245419 | [Model of motion sickness in white mice experiments] |
Q71801707 | [Modelling of the space form of motion sickness] |
Q68915676 | [Motion sickness and cerebral circulation] |
Q78944001 | [Motion sickness and hypercholesterolemia.] |
Q70050560 | [Motion sickness and its treatment (author's transl)] |
Q76078520 | [Motion sickness and its treatment.] |
Q84745954 | [Motion sickness at sea and in the air] |
Q74470801 | [Motion sickness in animals] |
Q86098992 | [Motion sickness in lower vertebrates: studies under conditions of weightlessness and under land conditions] |
Q75900418 | [Motion sickness of sea, land and air transportation; its importance in the army; therapy.] |
Q74470797 | [Motion sickness: pathogenesis and treatment] |
Q73797835 | [Motion sickness; history, etiology and pathogenesis] |
Q75829988 | [Motion sickness; importance in the army; therapy.] |
Q75844864 | [Motion sickness; its importance in the army; therapy] |
Q76126897 | [Motion sickness; results with synopen (Geigy) in seasickness.] |
Q80182449 | [Neuroendocrine factors in pathogenesis of motion sickness and the protective effect of drugs] |
Q75813687 | [On prophylaxis of sea sickness and motion sickness in general.] |
Q72104235 | [Optokinetic effects and the development of motion sickness] |
Q83892002 | [Orientation taping magnetic granules at auricular points and Neiguan (PC 6) for prevention and treatment of 102 cases of motion sickness] |
Q67918037 | [Participation of endogenous opioid peptides in the pathogenesis of motion sickness] |
Q69602080 | [Permeability of the blood-brain barrier in modeling motion sickness] |
Q79665948 | [Pharmaceutical evaluation of motion sickness remedies from the standpoint of aviation medicine.] |
Q73459061 | [Pharmacological prophylaxis of vestibulo-autonomous syndrome (motion sickness) in model investigations] |
Q69600776 | [Phase correlation of cupular and otolithic reactions and their interrelation with the development of motion sickness] |
Q69721148 | [Physiological reactions in motion sickness] |
Q79242370 | [Physiopathology of motion sickness studied in the light of its therapy.] |
Q72037013 | [Predisposition and therapy of motion sickness] |
Q53881333 | [Prevention and treatment of motion sickness] |
Q73206442 | [Prevention and treatment of nausea and vomiting of motion sickness] |
Q69630945 | [Prevention and treatment of the symptom complex in motion sickness] |
Q70671530 | [Prevention of motion sickness with a transdermal therapeutic system containing scopolamine. A randomized, comparative double-blind study in the German Federal Navy] |
Q85752648 | [Progress on the study of the relationship between arginine vasopressin and motion sickness] |
Q77187849 | [Relationship between EGG and the dynamic process of motion sickness induced by optokinetic vection] |
Q83841475 | [Relationships between constitutional types of traditional Chinese medicine and motion sickness in 145 ocean sailors] |
Q69488797 | [Role of changes in the hormonal status of man during the development of motion sickness] |
Q70940004 | [Role of external respiration in the formation of the autonomic component in motion sickness] |
Q71475355 | [Role of the autonomic nervous system in regulating intestinal glucose absorption during motion sickness] |
Q72078998 | [Role of the nonspecific afferent system in vestibular analyzer reactions (genesis of the motion sickness syndrome)] |
Q72096133 | [Significance of vestibular trophic function in the mechanism of the vestibulo-autonomic manifestations of motion sickness] |
Q69527608 | [Space motion sickness] |
Q51608570 | [Specific features of the motor function of the digestive organs in persons with different degree of resistance to motion sickness] |
Q70940067 | [Structure of nocturnal sleep and susceptibility to motion sickness] |
Q73383559 | [Studies on the value of cupulometry as an objective and reproducible measure of predisposition to motion sickness] |
Q91267704 | [THE EFFECT OF MOTION SICKNESS ON THE SLEEP-WAKE CYCLE IN RATS EXPOSED TO PRENATAL HYPOXIA] |
Q69274479 | [The cerebrovascular effects of motion sickness] |
Q72290764 | [The condition of hemodynamic indices as a criterion in the evaluation of motion sickness] |
Q74131282 | [The human alpha(2A)-AR gene and the genotype of site -1296 and the susceptibility to motion sickness] |
Q70164453 | [The motion sickness under reversing goggles (1st report)] |
Q84075351 | [The relationship of the content of AVP and the expression of V1b receptors in some brain areas with the sexual difference in the susceptibility of motion sickness in rats] |
Q75803737 | [The sea, ground and motion sickness; its military importance and its therapy] |
Q67828909 | [The spontaneous and evoked neuronal activity of the parietal associative cortex in cats during motion sickness] |
Q95414843 | [The stabilometric evaluation of resistance to motion sickness in man] |
Q73201125 | [The structural variability of the otolithic apparatus and the problem of motion sickness] |
Q72409169 | [Transportation-related disease or motion sickness] |
Q69520285 | [Treatment of Méniére's disease, otogenic vestibulopathies and motion sickness by the method of rectal administration of sodium bicarbonate suppositories] |
Q78688427 | [Treatment of motion sickness by a new medicinal combination.] |
Q68806118 | [Use of central electroanalgesia to restore the body's functional state in motion sickness] |
Q93640970 | [Use of reflexotherapy in the prevention and treatment of motion sickness] |
Q82365935 | [Vestibular testing abnormalities in individuals with motion sickness] |
Q70471236 | [Visual prevention from motion sickness in cars] |
Q113297469 | БСЭ1/Морская болезнь |
Q24789535 | МЭСБЕ / Морская болезнь |
Q83997755 | НЭС / Морская болезнь |
Q24350061 | ЭСБЕ / Болезнь морская |
Q252485 | The Great Wave off Kanagawa | depicts | P180 |
Q18698915 | Category:Motion sickness | category's main topic | P301 |
uri / http://www.wikidata.org/entity/L1261455-S1 | L1261455-S1 | item for this sense | P5137 |
Arabic (ar / Q13955) | داء الحركة | wikipedia |
az | Dəniz xəstəliyi | wikipedia |
Хвароба руху | wikipedia | |
be-tarask | Хвароба руху | wikipedia |
Кинетоза | wikipedia | |
bn | গতিজনিত অসুস্থতা | wikipedia |
Catalan (ca / Q7026) | Cinetosi | wikipedia |
Kinetóza | wikipedia | |
cy | Salwch symud | wikipedia |
Bevægelsessyge | wikipedia | |
Reisekrankheit | wikipedia | |
dv | ހަރަކާތުގެ ބަލި | wikipedia |
Ναυτία | wikipedia | |
Motion sickness | wikipedia | |
Esperanto (eo / Q143) | Movmalsano | wikipedia |
Cinetosis | wikipedia | |
Basque language (eu / Q8752) | Zinetosi | wikipedia |
Persian (fa / Q9168) | بیماری حرکت | wikipedia |
Matkapahoinvointi | wikipedia | |
Cinétose | wikipedia | |
ga | Tinneas gluaisne | wikipedia |
מחלת ים | wikipedia | |
Utazási betegség | wikipedia | |
Mabuk gerak | wikipedia | |
Sjóveiki | wikipedia | |
Chinetosi | wikipedia | |
乗り物酔い | wikipedia | |
ზღვის ავადმყოფობა | wikipedia | |
Теңіз ауруы | wikipedia | |
km | ជំងឺពុលឡាន | wikipedia |
멀미 | wikipedia | |
Jūras slimība | wikipedia | |
nb | Bevegelsessyke | wikipedia |
Reisziekte | wikipedia | |
or | ଗତି ରୋଗ | wikipedia |
Choroba lokomocyjna | wikipedia | |
Cinetose | wikipedia | |
Rău de mișcare | wikipedia | |
Морская болезнь | wikipedia | |
Serbo-Croatian (sh / Q9301) | Bolest kretanja | wikipedia |
Болест кретања | wikipedia | |
Rörelsesjuka | wikipedia | |
ta | பயணப்பிணி | wikipedia |
การเมาเหตุเคลื่อนไหว | wikipedia | |
Kinetozis | wikipedia | |
Tatar language (tt / Q25285) | Диңгез чире | wikipedia |
Хвороба руху | wikipedia | |
uz | Dengiz kasalligi | wikipedia |
Say tàu xe | wikipedia | |
yue | 暈浪 | wikipedia |
晕动病 | wikipedia | |
Merehaigus | wikiquote | |
Морская болезнь | wikiquote | |
Motion sickness | wikivoyage |
Search more.